ÂÜÀòÂÒÂ×

Gary Keller has over 30 years of experience in international business development and global technology-led economic development. He has worked for leading biotechnology and life science companies, worked within public, private, and federal entities, and is responsible for the development, funding, and launch of numerous technology and commercialization initiatives and startup companies.

Gary provides services primarily in the biomedical and environmental health fields and on economic development-focused projects. He is the founder and CEO of Xomix Ltd., a technology accelerator and consultancy engaged in intellectual asset management, commercialization, and technology-led economic development initiatives. Gary has served in leadership roles involving the development and launch of new initiatives, including the WIPO Guide on the Commercialization of Intellectual Property (IP), the Florida Institute for the Commercialization of Public Research, the BiTmaP Bioinformatics Training Program, NantKwest (NK NASDAQ), and the Cell Therapy market for Lonza Walkersville. He has more than 30 years of experience in corporate, institutional, and start-up business development including product development, sales, marketing, and scientific R&D.